Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

The U.S. Food and Drug Administration approved Qfitlia for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Sensei Biotherapeutics' solnerstotug shows a 14% ORR in PD-(L)1 resistant tumors and remains well tolerated in early trial data from its Phase 1/2 study.

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...